Showing results (31-40 of 260) with videos related to
Sort By:
Pageof 26
Frontiers in Pain Research (Lausanne, Switzerland)|June 20, 2022
Rapid-Onset Opioids for Management of Breakthrough Cancer Pain: Considerations for Daily PracticePaolo Bossi, Yolanda Escobar, Federico PeaThe Journal of Antimicrobial Chemotherapy|November 29, 2023
Therapeutic drug monitoring of ceftazidime/avibactam: why one leg is not enough to runMilo Gatti, Pierluigi Viale, Federico PeaAntimicrobial Agents and Chemotherapy|July 1, 2015
Pharmacokinetics and pharmacodynamics of continuous-infusion meropenem in pediatric hematopoietic stem cell transplant patientsPiergiorgio Cojutti, Natalia Maximova, Federico PeaClinical Pharmacokinetics|June 20, 2008
Clinical relevance of pharmacokinetics and pharmacodynamics in cardiac critical care patientsFederico Pea, Federica Pavan, Mario FurlanutBasic & Clinical Pharmacology & Toxicology|April 19, 2017
A 10-Year Experience of Therapeutic Drug Monitoring (TDM) of Linezolid in a Hospital-wide Population of Patients Receiving Conventional Dosing: Is there Enough Evidence for Suggesting TDM in the Majority of Patients?Federico Pea, Pier Giorgio Cojutti, Massimo BaraldoClinical Pharmacokinetics|July 4, 2014
Levofloxacin dosing regimen in severely morbidly obese patients (BMI ≥40 kg/m(2)) should be guided by creatinine clearance estimates based on ideal body weight and optimized by therapeutic drug monitoringManjunath P Pai, Piergiorgio Cojutti, Federico PeaClinical Pharmacokinetics|April 9, 2015
Pharmacokinetics and pharmacodynamics of continuous infusion meropenem in overweight, obese, and morbidly obese patients with stable and unstable kidney function: a step toward dose optimization for the treatment of severe gram-negative bacterial infectionsManjunath P Pai, Piergiorgio Cojutti, Federico PeaChemotherapy|August 5, 2025
Role of a TDM-guided strategy of isavuconazole for optimizing efficacy/safety outcomes in onco-hematological pediatric patients: a systematic reviewMilo Gatti, Pier Giorgio Cojutti, Federico PeaExpert Review of Anti-Infective Therapy|April 1, 2020
The role of dalbavancin in the treatment of acute bacterial skin and skin structure infections (ABSSSIs)Alex Soriano, Gian Maria Rossolini, Federico PeaCNS Drugs|April 18, 2021
Clinically Significant Drug Interactions Between Psychotropic Agents and Repurposed COVID-19 TherapiesMilo Gatti, Fabrizio De Ponti, Federico PeaPageof 26